Cite
HARVARD Citation
Hogan, J. et al. (2020). Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial. BMJ open. 10 (9), p. . [Online].